|

RCVR (Residual CardioVascular Risk) Prospective Multicenter Study

RECRUITINGSponsored by CHA University
Actively Recruiting
SponsorCHA University
Started2024-06-17
Est. completion2029-06-17
Eligibility
Age20 Years – 90 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06619353

Summary

The observational study aims to evaluate the long-term effects of residual cardiovascular risk on clinical outcomes following percutaneous coronary intervention (PCI). This risk includes thrombotic, metabolic, inflammatory, and procedural factors, which are assessed 1 month after the intervention. The primary question the study seeks to answer is: What residual cardiovascular risk affects long-term clinical outcomes in patients undergoing PCI? Participants will undergo artificial intelligence-based quantitative coronary analysis after PCI and will have comprehensive laboratory tests conducted at 1 month to evaluate residual cardiovascular risk, and then annually for 3 years post-intervention to assess changes in this risk.

Eligibility

Age: 20 Years – 90 YearsHealthy volunteers accepted
Inclusion Criteria:

* Patients who have undergone percutaneous coronary intervention.
* Patients who have provided written informed consent.

Exclusion Criteria:

* Under 19 years of age.
* Pregnant, breastfeeding, or women of childbearing age.
* Currently has a malignancy or has a history of malignancy within the past 5 years.
* Life expectancy of less than 5 years.

Conditions2

Coronary Artery DiseaseHeart Disease

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.